The global surge in obesity is undeniably contributing to the increasing prevalence of T2DM, a chronic and progressive metabolic disorder characterized by the body’s inability to produce sufficient insulin or to effectively utilize the insulin it produces. This evidence concerns the gene INS and Other metabolic disease.